TARRYTOWN, N.Y. -- The Diagnostics Professional Testing Systems Division of Bayer HealthCare LLC, a member of the Bayer Group announced today that it has received U.S. Food and Drug Administration (FDA) approval for its second hepatitis B assay on the ADVIA Centaur(R) Immunoassay System in eleven weeks. The Anti-HBc-IgM assay, a fully automated test on its leading automated immunoassay platform -- the ADVIA Centaur Immunoassay System -- is used to aid in the diagnosis of hepatitis B virus (HBV) infections.
"The availability of the Anti-HBc-IgM assay is another step for Bayer in offering customers a total solution for their infectious disease testing panel, which will ultimately include the complete HBV panel, HAV, HCV(1) and HIV(1) assays," said John Nosenzo, senior vice president North America Region for Bayer Diagnostics' Professional Testing Systems. "The highly automated ADVIA Centaur System makes it much easier for the laboratory to run these assays in real time instead of in batches, shortening the turnaround time for physicians."
Due to the complex nature of the hepatitis B virus (HBV) lifecycle, a variety of tests including the Anti-HBc-IgM assay are used to detect infection, replication and immunity:
Anti-HBc-IgM is utilized with other HBV markers to help healthcare professionals define the clinical status of HBV infected patients. The Anti HBc-IgM assay, along with HBs Ag and HBc Total assays, may also be useful in the differentiation of acute and chronic HBV infections. Anti-HBs is used to detect a previous HBV infection, determine the presence of protective immunity from vaccination or evaluate the recovery of a patient from a HBV infection.
A worldwide health concern, HBV is the most common form of hepatitis with 350 million carriers globally. HBV is 100 times more infectious than HIV(2). More than 95 percent of adults infected with HBV recover within six months and develop immunity. The remaining 5 percent develop chronic hepatitis or become carriers of the virus, leading to disease complications occurring in both acute and chronic cases. An estimated 1.25 million Americans are chronically infected with HBV, with 20 to 30 percent acquiring their infections in childhood, according to the U.S. Centers for Disease Control and Prevention.
(1) Manufactured for Ortho-Clinical Diagnostics, Inc. by Bayer HealthCare LLC
(2) Hepatitis Foundation International. 30 Sunrise Terrace, Cedar Grove, NJ 07009-1423 http://www.hepfi.org/living/liv_abc.html
Source: Bayer HealthCare LLC
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.